Optimal Management of Myeloproliferative Neoplasms

home / peer-exchange / management-of-myeloproliferative-neoplasms
An Overview of Myeloproliferative Neoplasms

EP. 1: An Overview of Myeloproliferative Neoplasms

January 30th 2020
Common Signs and Symptoms of Polycythemia Vera

EP. 2: Common Signs and Symptoms of Polycythemia Vera

January 30th 2020
Signs of Progressive Polycythemia Vera

EP. 3: Signs of Progressive Polycythemia Vera

January 30th 2020
Goals of Therapy in Polycythemia Vera

EP. 4: Goals of Therapy in Polycythemia Vera

January 30th 2020
Role of Phlebotomy in Polycythemia Vera

EP. 5: Role of Phlebotomy in Polycythemia Vera

January 30th 2020
Can Hepcidin Reduce Iron Deficiency in Phlebotomy?

EP. 6: Can Hepcidin Reduce Iron Deficiency in Phlebotomy?

January 30th 2020
Symptoms, Diagnosis, and QoL in Patients With Myelofibrosis

EP. 7: Symptoms, Diagnosis, and QoL in Patients With Myelofibrosis

January 30th 2020
Risk Stratification in Myelofibrosis

EP. 8: Risk Stratification in Myelofibrosis

January 30th 2020
Symptom Control in Myelofibrosis

EP. 9: Symptom Control in Myelofibrosis

January 30th 2020
The Use of Ruxolitinib in Myelofibrosis

EP. 10: The Use of Ruxolitinib in Myelofibrosis

January 30th 2020
The Role of Fedratinib in Myelofibrosis

EP. 11: The Role of Fedratinib in Myelofibrosis

January 30th 2020
Combining Ruxolitinib With Other Agents

EP. 12: Combining Ruxolitinib With Other Agents

January 30th 2020
Treatment of Myelofibrosis: Emerging Therapies

EP. 13: Treatment of Myelofibrosis: Emerging Therapies

January 30th 2020
Treating Patients With Essential Thrombocytopenia

EP. 14: Treating Patients With Essential Thrombocytopenia

January 30th 2020
Emerging Therapies in Essential Thrombocytopenia

EP. 15: Emerging Therapies in Essential Thrombocytopenia

January 30th 2020